Hms Capital Management, LLC Merck & Co., Inc. Transaction History

Hms Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	BUY	$84.53 - $94.96 $10,735 - $12,059	127 Added 5.01%	2,660 $229,000
Q2 2022 Jul 27, 2022	BUY	$83.49 - $94.64 $211,480 - $239,723	2,533 New	2,533 $231,000
Q1 2020 Apr 27, 2020	SELL	$63.36 - $87.82 $95,483 - $132,344	-1,507 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$77.58 - $87.54 $116,913 - $131,922	1,507 New	1,507 $137,000
Q3 2019 Oct 15, 2019	SELL	$76.08 - $82.93 $114,652 - $124,975	-1,507 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$69.84 - $81.59 $105,248 - $122,956	1,507 New	1,507 $126,000
Q1 2019 Apr 24, 2019	SELL	$69.58 - $79.36 $335,027 - $382,118	-4,815 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$50.83 - $59.72 $244,746 - $287,551	4,815 New	4,815 $292,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Hms Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hms Capital Management, LLC with notifications on news.